Global Leaders in Mobile ECG Connectivity
- 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring platforms, research groups and commercial call centers
- Sold into > 20 countries, with the largest customer base located in the US
- Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and storing of ECGs for management of patient and consumer health
- ECG solutions for both consumer (OTC) and medical (Rx) markets
- Owns all IP and source code
- Market expert contributor for reports in mâ€health, mobile cardiac monitoring and new advances in consumer health and wellness monitoring
Recent Highlights
Physician Groups Order The Heartcheck(TM) Cardibeat For In-Home Arrhythmia And Atrial Fibrillation Monitoring
- Confirms market traction with orders being placed by physician groups for the newly launched HeartCheck™ CardiBeat Handheld ECG monitor and GEMS™ Mobile Smartphone app for prescribed in-home arrhythmia monitoring.
- Partners in Advanced Cardiac Evaluation, the largest arrhythmia practice in Ontario (Canada) placed a first order of the HeartCheck™ CardiBeat Handheld ECG monitors and is recommending its patients to use the devices for one year of in-home, self-monitoring with an emphasis on detecting a recurrence of Atrial Fibrillation following cardiac ablation treatment for AF.
Industry News
- INDUSTRY BULLETIN: Scripps Researchers Use mHealth Wearables to Track Flu Outbreaks
- INDUSTRY BULLETIN: Current And Future Doctors Are More Than Ready to Use mHealth Wearables
- INDUSTRY BULLETIN: mHealth Market is Expected to Be the Fastest Growing By 2025
- INDUSTRY BULLETIN: Payers Are Using mHealth, Telehealth to Promote Better Health Outcomes
Company Accolades
FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.
Visited 1 times, 1 visit(s) today
Last modified: July 13, 2026
